Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-DANCE: Temsirolimus with or without Dexamethasone for PAD
NCT03942601Phase 2Terminated
- Sponsor
- Mercator MedSystems
- Start
- Oct 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in Peripheral Arterial Disease (PAD), sponsored by Mercator MedSystems. Started Oct 2019; status: terminated.
02
Drugs
temsirolimus
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT03942601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03942601.